The Scan

What Can Be Learned

US News and World Report describes what consumers can glean from direct-to-consumer genetic tests.

Microsoft is exploring using DNA as a data storage device, Technology Review reports.

This Week in PLOS

In PLOS this week: common variants linked to neuroblastoma susceptibility, rabies virus phylogeography, and more.

At the Atlantic, Ed Yong reports that the Trump Administration is considering capping NIH's indirect cost payments at 10 percent.

Strain on Insurers

The New York Times writes that direct-to-consumer genetic tests could strain long-term care insurers.

House science committee members call on Trump to appoint a White House Office of Science and Technology Policy director, according to Popular Science.

This Week in Science

In Science this week: malaria resistance variants, and more.

Not So Much For It

In a hearing, US lawmakers noted their dissatisfaction with proposed NIH budget cuts, according to ScienceInsider.

The Retraction Watch co-creators warn about contaminated and counterfeit lab supplies in a Stat News column.

This Week in Nature

In Nature this week: PGBD5 involved in many pediatric solid tumors, and more.

Califf Joining Verily

The former commissioner of the US Food and Drug Administration, Robert Califf, is heading to Alphabet's Verily.

Two Australian organizations are appealing a patent covering much of the cattle genome, according to ABC.

Greater Test Adoption

According to the San Francisco Chronicle, insurance companies are behind the increase in genetic testing.

In Genome Biology this week: Mycobacterium tuberculosis population dynamics, mapping precision in GWAS, and more.

David Lipman, who has led the US National Center for Biotechnology Information for decades, is stepping down.

Researchers find that energy drinks could be dangerous for patients with familial long QT syndrome, according to Live Science.

Testing for Fitness

BBC News explores services that test consumers' DNA to tailor fitness and nutrition programs.

This Week in PNAS

In PNAS this week: functional genomic study of effects of anti-parasitic drugs, humped bladderwort genome assembly, and more.

Henri Termeer Dies

Henri Termeer, the former long-time head of Genzyme and "founder of the modern biotech industry," has died, the Boston Globe reports.

The Trump administration is considering choosing a non-scientist to oversee the USDA's Research, Education, and Economics division, Mashable reports.

New bills have been introduced across the US that aim to alter science education standards, according to Nature News.

This Week in PLOS

In PLOS this week: blood pressure and hypertension loci in people of African ancestry, Plasmodium vivax population genomics, and more.

Microbial Influence

Researchers have found a link between the microbiome and certain brain malformations, according to the New York Times.

After putting off his doctoral studies to find rock-and-roll fame, the Offpring's Dexter Holland graduated this week with a Ph.D. in molecular biology from USC.

Dust off the Samples

UK researchers have dug into the archive to find more cancer samples for sequencing, Nature News reports.


The US National Institutes of Health's new plan will bolster support for early- and mid-career investigators.

Steven Hyman writes at Nature News that staff scientists could help research institutions take on ambitious research projects.

The NIH proposes using a Grant Support Index to limit the total amount of grant support any one principal investigator can have.

A survey of UK academics found that women tended to have higher teaching loads than men, according to Nature News.